News

Deal Announcements

Civitas Clears $20 Million First Venture Capital Round

Tuesday, January 11, 2011 5:32:00 AM PDT | VentureDeal Staff
Chelsea, Massachusetts  --  Pharmaceutical technology company Civitas Therapeutics has secured $20 million in its first round of financing according to a company statement.

Civitas is a spin out of Alkermes and is developing products with a dry powder pulmonary platform.

Longitude Capital and Canaan Partners led the round, which included other undisclosed investors.

The company said it would use the funding proceeds to advance its lead program.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1